Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines

M S Elmasry, Ian S Blagbrough, Michael G Rowan, H M Saleh, A A Kheir, Philip J Rogers

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

An HPLC method for the quantitative analysis of mebeverine HCl, 5-aminosalicylic acid (5-ASA), sulphasalazine and dispersible aspirin has been developed and then applied to these specific medicines when stored, with other medications, in Venalink blister packs (monitored dosage system) for periods of up to 35 days. Chromatographic separation was achieved on a reversed-phase C-12 column with an isocratic mixture of methanol, water and acetic acid as the mobile phase. The method was validated regarding: accuracy, precision, detection limits, quantification limits, specificity and robustness.
Original languageEnglish
Pages (from-to)646-652
Number of pages7
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume54
Issue number4
DOIs
Publication statusPublished - 25 Mar 2011

Fingerprint

Mesalamine
Sulfasalazine
Acetic Acid
Aspirin
Medicine
Methanol
High Pressure Liquid Chromatography
Water
Blister
Chemical analysis
Limit of Detection
mebeverine

Keywords

  • mebeverine
  • aspirin
  • mesalazine
  • 5-Aminosalicylic acid
  • sulphasalazine

Cite this

@article{1d3b5fc6dbdc4420af96aee84cf7a4b1,
title = "Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines",
abstract = "An HPLC method for the quantitative analysis of mebeverine HCl, 5-aminosalicylic acid (5-ASA), sulphasalazine and dispersible aspirin has been developed and then applied to these specific medicines when stored, with other medications, in Venalink blister packs (monitored dosage system) for periods of up to 35 days. Chromatographic separation was achieved on a reversed-phase C-12 column with an isocratic mixture of methanol, water and acetic acid as the mobile phase. The method was validated regarding: accuracy, precision, detection limits, quantification limits, specificity and robustness.",
keywords = "mebeverine, aspirin, mesalazine, 5-Aminosalicylic acid, sulphasalazine",
author = "Elmasry, {M S} and Blagbrough, {Ian S} and Rowan, {Michael G} and Saleh, {H M} and Kheir, {A A} and Rogers, {Philip J}",
year = "2011",
month = "3",
day = "25",
doi = "10.1016/j.jpba.2010.10.002",
language = "English",
volume = "54",
pages = "646--652",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines

AU - Elmasry, M S

AU - Blagbrough, Ian S

AU - Rowan, Michael G

AU - Saleh, H M

AU - Kheir, A A

AU - Rogers, Philip J

PY - 2011/3/25

Y1 - 2011/3/25

N2 - An HPLC method for the quantitative analysis of mebeverine HCl, 5-aminosalicylic acid (5-ASA), sulphasalazine and dispersible aspirin has been developed and then applied to these specific medicines when stored, with other medications, in Venalink blister packs (monitored dosage system) for periods of up to 35 days. Chromatographic separation was achieved on a reversed-phase C-12 column with an isocratic mixture of methanol, water and acetic acid as the mobile phase. The method was validated regarding: accuracy, precision, detection limits, quantification limits, specificity and robustness.

AB - An HPLC method for the quantitative analysis of mebeverine HCl, 5-aminosalicylic acid (5-ASA), sulphasalazine and dispersible aspirin has been developed and then applied to these specific medicines when stored, with other medications, in Venalink blister packs (monitored dosage system) for periods of up to 35 days. Chromatographic separation was achieved on a reversed-phase C-12 column with an isocratic mixture of methanol, water and acetic acid as the mobile phase. The method was validated regarding: accuracy, precision, detection limits, quantification limits, specificity and robustness.

KW - mebeverine

KW - aspirin

KW - mesalazine

KW - 5-Aminosalicylic acid

KW - sulphasalazine

UR - http://www.scopus.com/inward/record.url?scp=78650253701&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/j.jpba.2010.10.002

U2 - 10.1016/j.jpba.2010.10.002

DO - 10.1016/j.jpba.2010.10.002

M3 - Article

VL - 54

SP - 646

EP - 652

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 4

ER -